January 20, 2012

Drug maker Bristol-Myers Squibb has donated $6.9 million to a nonprofit group that helps people pay for medical treatments, the company said.

January 20, 2012

It has become a perennial issue, and one that is likely to crop up at least once this year: patent settlements.


January 20, 2012

For all the talk about generic drugs and their potential to save piles of money for the country’s healthcare system, it’s going to be a while before many of them actually reach consumers because of the Food and Drug Administration’s huge backlog of generic drug regulatory approval applications.


January 20, 2012

In the Feb. 7, 2011, issue, Drug Store News named three major issues that would define 2011 for the world of generic drugs. Those issues were drug safety, generic user fees and patent settlements.

January 20, 2012

If the patent cliff were a sports team, Pfizer’s cholesterol-
lowering drug Lipitor (atorvastatin) would be its mascot.

January 20, 2012

Walgreens’ contract with Express Scripts expired, and millions of Walgreens customers covered by ESI were forced to either move their pharmacy business or come up with some other way to stick with Walgreens. Drug Store News interviewed Walgreens president and CEO Greg Wasson on what the company is doing to hold on to those customers and how it is appealing to payers.

January 19, 2012

As we welcome a new year, it is exciting to see all the changes headed our way. With all the movement around healthcare reform and technology, we in the pharmacy industry are quick to point out that this industry is years ahead of the rest of health care in terms of payment solutions and automated workflow. The rest of the industry is running to catch up — but right now the pharmacy industry is far from where we need to be to address critical factors in our industry. That said, there are tremendous opportunities that several companies are bringing forward with new technology that can truly revolutionize the delivery of health care.

January 19, 2012

Walgreens has transformed 68 locations in the Indianapolis market into health and daily living destinations.

January 19, 2012

Generic drug maker Watson Pharmaceuticals has launched its version of a contraceptive made by Bayer HealthCare Pharmaceuticals, Watson said.

January 18, 2012

A wide range of factors and "moving parts" will likely make 2012 a challenging year for pharmacy retailers as the economy, generic drugs and the dispute between Walgreens and Express Scripts figure prominently, analysts say.

January 18, 2012

Patent expirations of key blockbuster drugs and efforts by payers to contain costs are likely to bring strong growth to the global generic drug market in the next few years as market-earned revenues grow by more than $100 billion, according to an analysis by research firm Frost & Sullivan.

January 17, 2012

A committee formed by Taro Pharmaceutical Industries in December is continuing to evaluate an acquisition offer by India-based Sun Pharmaceutical Industries, Taro said.

January 16, 2012

The Food and Drug Administration has finished and sent to Congress its recommendations for a proposed Generic Drug User Fee Act, drawing praise from the generic drug industry.

January 16, 2012

The results of CVS Caremark’s study, which found that its Pharmacy Advisor program increased medication adherence rates and physician initiation of prescriptions, is important as it further underscores the benefits of the program, and those benefits are bound to becomes even greater as the retailer gears up for the next generation of the clinical program.

January 13, 2012

Bristol-Myers Squibb has officially launched its tender offer for Inhibitex, the drug maker said Friday.

January 13, 2012

British retail pharmacy chain Lloyds Pharmacy and U.S.-based Proteus Biochemical are collaborating to launch a digital health product that combines sensor-enabled tablets, a sensor patch and a mobile health application to help people with complex medication regimens and health issues.

January 10, 2012

CVS Caremark's chief healthcare strategy officer on Tuesday outlined how the company's integrated pharmacy-based program for such chronic diseases as diabetes, called Pharmacy Advisor, increased medication adherence rates and physician initiation of prescriptions for concomitant medications to improve patient health.

January 9, 2012

A CVS Caremark study found that the company's integrated pharmacy-based program — Pharmacy Advisor — increased medication adherence rates and physician initiation of prescriptions for concomitant medications, improving care for diabetes patients and resulting in savings for health plans, the company announced on Monday.

January 6, 2012

It's been a big week for Walgreens. Following its exit from Express Scripts' pharmacy network, the pharmacy retailer introduced a new program to help patients either keep their pharmacy home at Walgreens or to help transition them to a new pharmacy. Why help transition customers to the competition? Because it's the right thing to do. As Greg Wasson told DSN editor Rob Eder in an exclusive interview, "our No. 1 priority is to take care of patients."

January 4, 2012

The American Pharmacists Association has released a new information resource for pharmacists and pharmacy students about pharmacy management, the group said.

January 3, 2012

Mylan has launched a generic drug for treating high blood pressure, the company said.

January 3, 2012

While physicians and pharmacists alike generally view electronic prescribing with favor, several barriers stand in the way of their realizing its full benefit, according to a November government study.


January 3, 2012

Walgreens on Friday unveiled a plan to help Express Scripts patients to either continue using Walgreens when possible or to make a smooth transition to another community pharmacy.

December 23, 2011

Drug makers will focus on patient-specific therapies instead of drugs designed for use by a broad range of people over the next decade, according to a new report released Thursday by Thomson Reuters.